About Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals, Inc. is a product-focused pharmaceuticals company
engaged in the formulation, clinical testing, registration, manufacture,
sales and marketing of advanced pharmaceutical and genetic products in
mainland China. The Company's mission is to discover, develop and market
meaningful new therapies that improve human health. Aida Pharmaceuticals,
in operation since March 1999, is headquartered in Hangzhou, People's
Republic of China with manufacturing, distribution and sales points
throughout mainland China. Aida Pharmaceuticals, Inc. is GMP-certified in
the People's Republic of China and ISO9002-certified for quality assurance
and ISO14000 certified for ecologically-friendly practices.
For additional information, please visit http://en.aidapharma.com .
(310) 450-9100 opt 1
Safe Harbor Statement Under The Private Securities Litigation Reform
Act of 1995: Except for historical information contained herein, the
statements in this news release are forward-looking statements that are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements involve known and
unknown risks and uncertainties, which may cause a company's actual
results, performance and achievement in the future to differ materially
from forecasted results, performance, and achievement. These risks and
uncertainties are described in the Company's periodic filings with the
Securities and Exchange Commission. The Company undertakes no obligation to
publicly release the result of any revisions to these forward-looking
statements that may be made to reflect events or circumstances after the
|SOURCE Aida Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved